Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ringer's solution (University of Houston) refers to a specialized ocular hygiene formulation developed for use in lid scrubs, specifically studied for patients wearing scleral lenses. Unlike standard Ringer's solution, which is an isotonic electrolyte solution, this version is chemically modified to include surfactants and possess specific antimicrobial attributes. It is designed to treat blepharitis and improve scleral lens wear time by reducing microbial load on the eyelids and lens accessories. The formulation was evaluated in clinical trials (such as NCT03544385) sponsored by the University of Houston to determine its efficacy in enhancing ocular surface health and lens comfort.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ringer's solution (University of Houston).